[HTML][HTML] SARS CoV-2 infections in animals, two years into the pandemic
S Frazzini, M Amadori, L Turin, F Riva - Archives of Virology, 2022 - Springer
In December 2019, several cases of pneumonia caused by a novel coronavirus, later
identified as SARS-CoV-2, were detected in the Chinese city of Wuhan. Due to its rapid …
identified as SARS-CoV-2, were detected in the Chinese city of Wuhan. Due to its rapid …
[HTML][HTML] SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand
W Jairak, E Chamsai, K Udom, K Charoenkul… - Scientific Reports, 2022 - nature.com
Abstract In June–September 2021, we investigated severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) infections in domestic dogs and cats (n= 225) in Bangkok and …
coronavirus-2 (SARS-CoV-2) infections in domestic dogs and cats (n= 225) in Bangkok and …
Structural basis of white-tailed deer, Odocoileus virginianus, ACE2 recognizing all the SARS-CoV-2 variants of concern with high affinity
P Han, Y Meng, D Zhang, Z Xu, Z Li, X Pan… - Journal of …, 2023 - Am Soc Microbiol
ABSTRACT SARS-CoV-2 has been expanding its host range, among which the white-tailed
deer (WTD), Odocoileus virginianus, became the first wildlife species infected on a large …
deer (WTD), Odocoileus virginianus, became the first wildlife species infected on a large …
SARS-CoV-2 transmission from human to pet and suspected transmission from pet to human, Thailand
C Piewbang, P Poonsin, P Lohavicharn… - Journal of Clinical …, 2022 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been the cause of human pandemic infection …
syndrome coronavirus 2 (SARS-CoV-2), has been the cause of human pandemic infection …
Characterization of entry pathways, species-specific angiotensin-converting enzyme 2 residues determining entry, and antibody neutralization evasion of Omicron BA …
SN Neerukonda, R Wang, R Vassell, H Baha… - Journal of …, 2022 - Am Soc Microbiol
ABSTRACT The SARS-CoV-2 Omicron variants were first detected in November 2021, and
several Omicron lineages (BA. 1, BA. 2, BA. 3, BA. 4, and BA. 5) have since rapidly emerged …
several Omicron lineages (BA. 1, BA. 2, BA. 3, BA. 4, and BA. 5) have since rapidly emerged …
[HTML][HTML] A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain
S Villanueva-Saz, M Martínez, J Giner… - Veterinary Research …, 2023 - Springer
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 is the causative agent of
Coronavirus Disease 2019 in humans. Among domestic animals, cats are more susceptible …
Coronavirus Disease 2019 in humans. Among domestic animals, cats are more susceptible …
Possible cross-reactivity of feline and white-tailed deer antibodies against the SARS-CoV-2 receptor binding domain
TJ Hancock, P Hickman, N Kazerooni… - Journal of …, 2022 - Am Soc Microbiol
In late 2019, a novel coronavirus began circulating within humans in central China. It was
designated SARS-CoV-2 because of its genetic similarities to the 2003 SARS coronavirus …
designated SARS-CoV-2 because of its genetic similarities to the 2003 SARS coronavirus …
Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary bronchial epithelial cells
N Dinesh Kumar, BM ter Ellen, EM Bouma… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Antiviral therapies are urgently needed to treat and limit the development of severe COVID-
19 disease. Ivermectin, a broad-spectrum anti-parasitic agent, has been shown to have anti …
19 disease. Ivermectin, a broad-spectrum anti-parasitic agent, has been shown to have anti …
Species-specific molecular barriers to SARS-CoV-2 replication in bat cells
Bats are natural reservoirs of numerous coronaviruses, including the potential ancestor of
SARS-CoV-2. Knowledge concerning the interaction between coronaviruses and bat cells is …
SARS-CoV-2. Knowledge concerning the interaction between coronaviruses and bat cells is …
[HTML][HTML] Moxidectin and ivermectin inhibit SARS-CoV-2 replication in vero E6 cells but not in human primary bronchial epithelial cells
ND Kumar, BM Ter Ellen, EM Bouma… - Antimicrobial Agents …, 2022 - ncbi.nlm.nih.gov
Antiviral therapies are urgently needed to treat and limit the development of severe COVID-
19 disease. Ivermectin, a broad-spectrum anti-parasitic agent, has been shown to have anti …
19 disease. Ivermectin, a broad-spectrum anti-parasitic agent, has been shown to have anti …